Table 1.
Clinical differences between the study and control group.
| Variables | Study group PHPT (N = 48) | Control group (N = 30) | p |
|---|---|---|---|
| Age (years) | 66 (52–72) | 61 (54–68) | NS |
| Female (n/N) (%) | 40 (83.3) | 24 (80.0) | NS |
| Kidney stones (n/N) | 12 (25.0) | 3 (10.0) | 0.001 |
| Osteoporosis (n/N) | 14 (29.2) | 4 (13.3) | 0.004 |
| Hypertension (n/N) (%) | 28 (58.3) | 9 (30.0) | 0.028 |
| ACE inhibitors (n/N) (%) | 10 (35.7) | 4 (44.4) | NS |
| Diuretics (n/N) (%) | 9 (32.1) | 3 (33.3) | NS |
| Beta blockers (n/N) (%) | 11 (39.3) | 4 (44.4) | NS |
Normally distributed variables presented as x ± SD and skewed variables by median (interquartile range); categorical variables presented as n (%); NS—not significant; PHPT—Primary hyperparathyroidism; ACE—angiotensin converting enzyme.